Yun-Ping Lu Selected Research

Yun-Ping Lu Research Topics

Disease

17	Neoplasms (Cancer) 11/2010 - 12/2003
15	Ovarian Neoplasms (Ovarian Cancer) 09/2007 - 08/2003
7	Breast Neoplasms (Breast Cancer) 02/2009 - 12/2003
7	Carcinoma (Carcinomatosis) 06/2007 - 10/2003
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2012 - 03/2006
4	Neoplasm Metastasis (Metastasis) 01/2008 - 11/2004
3	Hypoxia (Hypoxemia) 01/2008 - 04/2005
3	Carcinogenesis 04/2007 - 07/2005
3	Ovarian Epithelial Carcinoma 07/2005 - 02/2004
1	Tissue Adhesions 04/2022
1	Burns 04/2022
1	Hemorrhage 04/2022
1	Wounds and Injuries (Trauma) 04/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2008
1	Leukemia 08/2006
1	Lymphatic Metastasis 03/2006
1	Infections 09/2005
1	Ascites 01/2005
1	Glioma (Gliomas) 10/2004
1	Adenocarcinoma 06/2003
1	Endometrial Hyperplasia 06/2003
1	Hyperplasia 06/2003
1	Endometrial Neoplasms (Endometrial Cancer) 06/2003

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 02/2007 - 06/2003
6	Messenger RNA (mRNA)IBA 12/2009 - 10/2003
4	Paclitaxel (Taxol)FDA LinkGeneric 04/2007 - 08/2003
3	EnzymesIBA 11/2010 - 11/2004
3	trichostatin A (A 300)IBA 02/2009 - 10/2005
2	Therapeutic UsesIBA 11/2010 - 12/2009
2	ImmunosorbentsIBA 11/2010 - 12/2009
2	Complementary DNA (cDNA)IBA 10/2008 - 10/2004
2	Cisplatin (Platino)FDA LinkGeneric 09/2007 - 10/2005
2	Pharmaceutical PreparationsIBA 09/2007 - 03/2004
2	Antisense RNA (Anti-Sense RNA)IBA 06/2007 - 01/2007
2	Histone Deacetylases (Histone Deacetylase)IBA 08/2006 - 10/2005
2	Histone Deacetylase InhibitorsIBA 08/2006 - 10/2005
2	theasinensin AIBA 08/2006 - 10/2005
2	SurvivinIBA 07/2005 - 02/2004
2	Antisense OligonucleotidesIBA 07/2005 - 12/2003
2	Matrix Metalloproteinases (MMPs)IBA 01/2005 - 11/2004
2	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2005 - 11/2004
2	Topotecan (Hycamtin)FDA LinkGeneric 03/2004 - 12/2003
2	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 03/2004 - 12/2003
1	HydrogelsIBA 04/2022
1	Drinking WaterIBA 01/2012
1	TeaIBA 01/2012
1	Protein Subunit VaccinesIBA 11/2010
1	VaccinesIBA 12/2009
1	Interferon-gamma (Interferon, gamma)IBA 12/2009
1	Interleukin-2 (IL2)IBA 12/2009
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2009
1	Peptides (Polypeptides)IBA 12/2009
1	CytokinesIBA 12/2009
1	Aquaporin 1IBA 01/2008
1	Hypoxia-Inducible Factor 1IBA 01/2008
1	VimentinIBA 01/2008
1	Monomeric GTP-Binding ProteinsIBA 10/2007
1	TOR Serine-Threonine KinasesIBA 04/2007
1	Sirolimus (Rapamycin)FDA Link 04/2007
1	NIMA-Interacting Peptidylprolyl IsomeraseIBA 03/2006
1	Tumor Biomarkers (Tumor Markers)IBA 03/2006
1	ezrinIBA 03/2006
1	Cadherins (E-Cadherin)IBA 03/2006
1	Cyclin D1IBA 03/2006
1	Phosphotransferases (Kinase)IBA 10/2005
1	adenovirus receptorIBA 10/2005
1	Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA 09/2005
1	antibiotic G 418IBA 09/2005
1	Cell Adhesion MoleculesIBA 09/2005
1	Liposomes (Liposome)IBA 07/2005
1	OligonucleotidesIBA 07/2005
1	cobaltous chloride (cobalt(II)chloride)IBA 04/2005
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2005
1	LigandsIBA 01/2005
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2005
1	Chemokine ReceptorsIBA 01/2005
1	CXC ChemokinesIBA 01/2005
1	Chemokine CXCL12IBA 01/2005
1	Butyric Acid (Butanoic Acid)IBA 01/2005
1	NucleotidesIBA 11/2004
1	Indicators and Reagents (Reagents)IBA 06/2004
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2004
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2004
1	Multidrug Resistance-Associated ProteinsIBA 03/2004
1	Thymidine KinaseIBA 12/2003
1	Biomarkers (Surrogate Marker)IBA 06/2003
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 06/2003
1	RNA (Ribonucleic Acid)IBA 06/2003

Therapy/Procedure

1	TP protocol 11/2010
1	Drug Therapy (Chemotherapy) 11/2010
1	Immunotherapy 11/2010
1	Radical Mastectomy 01/2008
1	Lasers (Laser) 01/2008
1	Therapeutics 11/2004